Haematology results, inflammatory haematological ratios, and inflammatory indices in cervical cancer: How is the difference between cancer stage?

doi:10.5493/wjem.v15.i1.96988

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (94)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-1) series.

Item

Count

PDF

HTML

Tables (1-1)

Sum=68

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=22

Publishing Process of This Article

Item

Count

Browse

Download

Sum=0

Mar 20, 2025 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Exp Med. Mar 20, 2025; 15(1): 96988
Published online Mar 20, 2025. doi: 10.5493/wjem.v15.i1.96988

Haematology results, inflammatory haematological ratios, and inflammatory indices in cervical cancer: How is the difference between cancer stage?

Phey Liana, Hanif Gusneri Syahbiran, Nurmalia Purnama Sari, Kemas Yakub Rahadiyanto, Raissa Nurwany, Wahyudi Nurhidayat, Tungki Pratama Umar

Phey Liana, Nurmalia Purnama Sari, Department of Clinical Pathology, Faculty of Medicine, Universitas Sriwijaya-Dr. Mohammad Hoesin General Hospital, Palembang 30114, Sumatera Selatan, Indonesia

Hanif Gusneri Syahbiran, Department of Medicine Programme, Faculty of Medicine, Universitas Sriwijaya, Palembang 30114, Sumatera Selatan, Indonesia

Kemas Yakub Rahadiyanto, Department of Clinical Pathology, Faculty of Medicine, Universitas Sriwijaya, Palembang 30114, Sumatera Selatan, Indonesia

Raissa Nurwany, Department of Physiology and Medical Physics, Faculty of Medicine, Universitas Sriwijaya, Palembang 30114, Sumatera Selatan, Indonesia

Wahyudi Nurhidayat, Department of Radiotherapy, Dr. Mohammad Hoesin General Hospital, Palembang 30114, Sumatera Selatan, Indonesia

Tungki Pratama Umar, Division of Surgery and Interventional Science, Faculty of Medical Sciences, University College London, London WC1E 6BT, United Kingdom

Author contributions: Liana P and Sari NP conceptualized the study; Liana P and Syahbiran HG performed the research; Liana P, Sari NP, Rahadiyanto KY, Nurwany R, and Umar TP determined the methodology; Liana P, Sari NP, Rahadiyanto KY, Nurwany R, Nurhidayat W, and Umar TP conducted data validation and analysis; Liana P, Syahbiran HG, Sari NP, and Umar TP wrote the manuscript; Liana P and Umar TP revised the manuscript for important intellectual content; and all authors have read and approved the final version of the manuscript.

Institutional review board statement: The study has received approval from the medical and health research ethics committees of the Faculty of Medicine, Universitas Sriwijaya, under Protocol No. 301-2023.

Informed consent statement: No identifiable human data were used for this study.

Conflict-of-interest statement: All the authors report having no relevant conflicts of interest for this article.

Data sharing statement: No additional data are available.

STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Phey Liana, MBBS, MD, PhD, Associate Professor, Lecturer, Researcher, Department of Clinical Pathology, Faculty of Medicine, Universitas Sriwijaya-Dr. Mohammad Hoesin General Hospital, Dr. Mohammad Ali Street, RSMH Complex Palembang, Indonesia, Palembang 30114, Sumatera Selatan, Indonesia. pheyliana@fk.unsri.ac.id

Received: May 20, 2024
Revised: October 22, 2024
Accepted: November 1, 2024
Published online: March 20, 2025
Processing time: 219 Days and 17.1 Hours

Core Tip

Core Tip: The current investigation of 208 adult cervical patients found that hematologic parameters such as leucocyte, neutrophil, monocyte, and platelet counts vary significantly depending on the cervical cancer clinical stage. There were significant changes in inflammatory haematological ratios (neutrophil-lymphocyte ratio/NLR, platelet-lymphocyte ratio/PLR, and lymphocyte-monocyte ratio/LMR) and inflammatory indices (systemic immune-inflammation index/SII and systemic inflammation response index/SIRI), particularly between patients with stage III + IV and those with stage II and I cervical cancer. The analysis revealed that the cervical cancer clinical stage is highly related to the hematologic parameters.